Breast cancers: Estrogen and progesterone receptor status as a predictor of in vitro chemotherapeutic response-Reference-Cited by-同舟云学术

Breast cancers: Estrogen and progesterone receptor status as a predictor of in vitro chemotherapeutic response

Published:1984-10 Issue:4 Volume:37 Page:257-263
ISSN:0022-4804
Container-title:Journal of Surgical Research
language:en
Short-container-title:Journal of Surgical Research

Author:

Bertelsen Carl A.,Giuliano Armando E.,Kern David H.,Mann Barry D.,Roe Denise J.,Morton Donald L.

Publisher

Elsevier BV

Subject

Surgery

Reference29 articles.

1. Association between steroid hormone receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer;Allegra;Cancer Treat Rep.,1978

2. The variability of estrogen receptors in metastatic breast cancer;Brennan;Amer. J. Surg.,1979

3. The dilemma of estrogen receptors and the response rate to cytotoxic chemotherapy;Carter;Cancer Clin. Trials,1979

4. Heterogeneity of tumor cells from a single mouse mammary tumor;Dexter;Cancer Res.,1978

5. Estrogen receptors and breast cancer: Progestin and therapeutic implications;Gapinski;Surgery,1980

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18 F–labeled estradiol derivative for targeting estrogen receptor-expressing breast cancer;Nuclear Medicine and Biology;2018-04

2. The Assessment of Estrogen Receptor Status and Its Intratumoral Heterogeneity in Patients With Breast Cancer by Using 18F-Fluoroestradiol PET/CT;Clinical Nuclear Medicine;2017-06

3. High specific activity is not optimal:18F-fluoroestradio positron emission tomography-computed tomography results in a breast cancer xenograft;Journal of Labelled Compounds and Radiopharmaceuticals;2016-10-13

4. Synthesis and evaluation of 7α-(3-[18F]fluoropropyl) estradiol;Nuclear Medicine and Biology;2015-07

5. Can Fluorine-18 Fluoroestradiol Positron Emission Tomography–Computed Tomography Demonstrate the Heterogeneity of Breast Cancer In Vivo?;Clinical Breast Cancer;2013-10